Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Anthem

CVS Health

Teladoc

Telemedicine has emerged as the need of the hour for homebound Americans seeking medical expertise because of the pandemic.

4 Telehealth Stocks Amid Coronavirus-Led Lockdown

Cigna

Molina Healthcare

UnitedHealth Group

Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.

Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks

Humana (HUM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well

Why Humana (HUM) Stock Might be a Great Pick

Cintas Corp

Dolby Laboratories

Domino's Pizza

W.W. Grainger

Home Depot

New Linde PLC

Mastercard

Merck

Microsoft

Roper Technologies

Sherwin-Williams

T. Rowe Price Group

Visa

The longest bull market in history has blown up in spectacular fashion, thanks to the coronavirus pandemic that has shut economic activity all around the world.

15 Super-Safe Dividend Stocks to Buy Now

Humana (HUM) to excuse members' out-of-pocket costs for COVID-19 treatment.

Humana to Waive Expenses Related to Coronavirus Treatment

The insurers could benefit from the move.

Cigna and Humana Join Aetna in Waiving COVID-19 Patients' Cost-Sharing Payments

Select Medical Holdings

SEM vs. HUM: Which Stock Is the Better Value Option?

SEM vs. HUM: Which Stock Should Value Investors Buy Now?

Health insurance companies Cigna Corp. (NYSE: CI) and Humana Inc. (NYSE: HUM) will waive all out-of-pocket expenses for novel coronavirus (COVID-19) patients, President Donald Trump announced in a press conference on Sunday.

Insurers Cigna, Humana Waive Out-Of-Pocket Costs For Coronavirus Patients

The insurers said the waiver applies to all medical costs related to the treatment of coronavirus, including FDA-approved medications and vaccines when they become available.

Cigna and Humana waive coronavirus treatment costs

Health insurers Cigna and Humana are waiving customer cost-sharing and co-payments for all treatments related to the Coronavirus strain COVID-19.

Cigna, Humana Waive Patient Out-Of-Pocket Costs For All Coronavirus Treatment

Humana saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 90 the day before. 
The post Humana Earns Membership In 95-Plus Composite Rating Club appeared first on Investor's Business Daily.

Humana Earns Membership In 95-Plus Composite Rating Club

Humana (HUM) enhances its telehealth service facilities to combat the spread of COVID-19.

Humana (HUM) Extends Telehealth Services to Fight Coronavirus

AutoZone

Becton, Dickinson and Co.

Becton Dickinson & Co. Deposit Repr 1/20th Cum Conv Pfd Registered Series A

Hershey

LogMeIn

Mettler-Toledo

O'Reilly Automotive

Top Stocks To Own As Coronavirus Epidemic Shocks US Stocks.  A Coronavirus Portfolio to help you invest in the current market tumult.

Top Stocks To Own As Coronavirus Epidemic Shocks US Stocks

Humana (HUM) consistently thrives on the back of its well-performing Medicare business.

Humana (HUM) Continues to Ride on Medicare Business Momentum

Humana (HUM) reported earnings 30 days ago. What's next for the stock?

Humana (HUM) Up 3.2% Since Last Earnings Report: Can It Continue?

Investors are responding enthusiastically to the changing dynamics in the Democratic presidential race.

Here's Why Big Health Insurance Stocks Are Soaring Today

Humana (HUM) strengthens ties with Aledade to expand value-based care services for its Medicare Advantage members in North Carolina.

Humana Extends Value-based Care Services in North Carolina

Datadog

Block

Installed Building Products

Five highfliers are in or near buy zones, including Domino's Pizza, Square, Humana, Datadog and Installed Building Products.
The post Domino's Pizza, Square, Humana, Datadog: Stocks To Watch In Or Near Buy Zones appeared first on Investor's Business Daily.

Domino's Pizza, Square, Humana, Datadog: Stocks To Watch In Or Near Buy Zones

Aetna

HCA Healthcare

iShares U.S. Healthcare Providers ETF

iShares U.S. Consumer Services ETF

Invesco WilderHill Clean Energy ETF

President Donald Trump delivered his latest budget proposal for 2021 and out these ETFs in focus.

Trump Budget 2021 Likely to Impact These Sector ETFs

Express Scripts Holding

Walgreens

WellCare Health Plans

The U.S. health insurance market, roiled by transformative deals in recent years, will likely face a lull in major deal activity in 2020 while firms await critical federal election outcomes.

Feel The Bern: Presidential Race Throws Cold Water On Health Insurance Mega-Mergers

Humana, Inc. (HUM) CEO Bruce Broussard on Q4 2019 Results - Earnings Call Transcript

The health insurer especially benefited from strong growth in its Medicare business.

How Humana Beat Expectations Again in Q4

Humana’s chief executive said the company will add another 270,000 to 330,000 seniors to its Medicare Advantage plans in 2020 on top of the “more than a half million” added in 2019 as more seniors flock to private plans that contract with the government for their health benefits.

As Humana Invests In Clinics, Medicare Business Adds 523K Seniors

Humana (HUM) delivered earnings and revenue surprises of 3.64% and 0.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Humana (HUM) Beats Q4 Earnings and Revenue Estimates

Shares of Humana Inc. HUM, +2.90% were indicated up nearly 1% in premarket trading Wednesday, after the health plan administration company reported fourth-quarter profit and revenue that beat expectations, citing a "solid performance" by the company's Medicare Advantage and Healthcare Services business.

News for Humana Stock (HUM)